SUN PHARMA Surges by 7%; BSE HEALTHCARE Index Up 0.4%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  •
  • MyStocks
MEMBER'S LOGIN

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Surges by 7%; BSE HEALTHCARE Index Up 0.4%
Fri, 13 Mar 10:51 AM

SUN PHARMA share price has zoomed 7% and is presently trading at Rs 390.

Meanwhile, the BSE HEALTHCARE Index is at 12,298 (up 0.4%).

Among the top Gainers in the BSE HEALTHCARE Index today are SUN PHARMA (up 7.4%) and AUROBINDO PHARMA (up 10.0%).

NARAYANA HRUDAYALAYA LTD and SUN PHARMA ADV. RES. (down 0.4%) are among the top losers today.

Over the last one year, SUN PHARMA has moved down from Rs 470 to Rs 390, registering a loss of Rs 80 (down 19.0%).

On the other hand, the BSE HEALTHCARE has moved down from 14,333 to 12,298, loss of 2,035 points (down 14.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 90.4%), DR. LAL PATHLABS LTD (up 48.9%) and J.B.CHEMICALS (up 48.8%).

Urgent Release: My Special Report on How to Trade the Coronavirus Crash

What About the Benchmark Indices?

The BSE Sensex is at 32,392 (down 1.3%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 7.4%), HDFC (up 1.7%) and BAJAJ FINANCE (up 0.7%). Other gainers include BHARTI AIRTEL (up 0.4%) and ICICI BANK (up 0.3%). The most traded stocks in the BSE Sensex are HDFC BANK and ICICI BANK.

In the meantime, NSE Nifty is at 9,520 (down 1.0%). SUN PHARMA (up 7.7%) and YES BANK (up 6.4%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,536 to 32,392, registering a loss of 5,144 points (down 13.8%).

SUN PHARMA Financial Update...

SUN PHARMA net profit down at Rs 10 billion for the quarter ended December 2019, compared to a loss of Rs 15 billion a year ago. Net Sales rose 5.4% to Rs 81.5 billion during the period as against Rs 77.4 billion in October-December 2018.

For the year ended March 2019, SUN PHARMA reported 25.7% increase in net profit to Rs 44.2 billion compared to net profit of Rs 35.2 billion during FY18.

Revenue of the company grew 9.7% to Rs 291 billion during FY19.

The current Price to earnings ratio of SUN PHARMA, based on rolling 12 month earnings, stands at 20.7x.

Archives

RSS RSS



What else is happening in the markets today? Dig in...

Advertisement
Just Released! Our Special Report on the Coronavirus Crisis
The foundation for great wealth is laid in times of crisis... Here's how you could tap into the coronavirus crisis and potentially set yourself up for massive gains in the years to come. How to Trade the Coronavirus Crash - 1-Click FREE DOWNLOAD...

Equitymaster requests your view! Post a comment on "SUN PHARMA Surges by 7%; BSE HEALTHCARE Index Up 0.4%". Click here!

  

Stock Market Updates

Sensex Ends 4.6% Lower, FII Outflows, Stocks to Watch Out, and Top Cues in Focus Today (Today's Market)

Mar 31, 2020 Pre-Open

Indian share markets witnessed selling pressure throughout the trading session yesterday and ended deep in the red with Sensex and Nifty witnessing a sharp fall during closing hours.

Sensex Tanks 1,375 Points; Nifty Ends Below 8,300 Mark (Today's Market)

Mar 30, 2020 Closing

While the BSE Sensex closed lower by 1,375 points, NSE Nifty closed lower by 379 points.

PROCTER & GAMBLE HEALTH Surges by 6%; BSE HEALTHCARE Index Up 0.8% (Today's Market)

Mar 30, 2020 03:34 PM

PROCTER & GAMBLE HEALTH share price has surged by 6% and its current market price is Rs 3,499. The BSE HEALTHCARE is up by 0.8%. The top gainers in the BSE HEALTHCARE Index are PROCTER & GAMBLE HEALTH (up 6.3%) and ABBOTT INDIA (up 8.2%). The top losers are CADILA HEALTHCARE (down 0.1%) and J.B.CHEMICALS (down 0.2%).

SECURITY AND INTELLIGENCE SER. Plunges by 6%; BSE 500 Index Down 3.6% (Today's Market)

Mar 30, 2020 03:34 PM

SECURITY AND INTELLIGENCE SER. share price has plunged by 6% and its current market price is Rs 438. The BSE 500 is down by 3.6%. The top gainers in the BSE 500 Index are AIA ENGINEERING (up 14.5%) and BLUE DART EXPRESS (up 13.4%). The top losers are SECURITY AND INTELLIGENCE SER. (down 5.9%) and EICHER MOTOR (down 6.6%).

PVR LTD Plunges by 6%; BSE 500 Index Down 3.6% (Today's Market)

Mar 30, 2020 03:34 PM

PVR LTD share price has plunged by 6% and its current market price is Rs 1,271. The BSE 500 is down by 3.6%. The top gainers in the BSE 500 Index are AIA ENGINEERING (up 14.5%) and BLUE DART EXPRESS (up 13.4%). The top losers are PVR LTD (down 6.1%) and EICHER MOTOR (down 6.6%).

CAPRI GLOBAL CAPITAL Plunges by 5%; BSE 500 Index Down 3.6% (Today's Market)

Mar 30, 2020 03:34 PM

CAPRI GLOBAL CAPITAL share price has plunged by 5% and its current market price is Rs 173. The BSE 500 is down by 3.6%. The top gainers in the BSE 500 Index are AIA ENGINEERING (up 14.5%) and BLUE DART EXPRESS (up 13.4%). The top losers are CAPRI GLOBAL CAPITAL (down 5.1%) and EICHER MOTOR (down 6.6%).

View More Indian Share Market News

Most Popular

If I Were to Recommend One Stock Amid Coronavirus Outbreak, This Would be It.(Profit Hunter)

Mar 19, 2020

Coronavirus outbreak has made no impact on the long term prospects of my favourite smallcap. What it has indeed done is brought the company below my buy price, making it even more attractive investment at current price.

Why India Will Be the Biggest Winner in a Post-Coronavirus World(The 5 Minute Wrapup)

Mar 19, 2020

The way businesses operate will change in a major way post the coronavirus impact. Here's why India stands to benefit from this change...

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

How to Trade the Coronavirus Crash - Download this FREE Report Now
How to Profit Even During These Times of Crisis: Vijay Bhambwani Reveals his Strategy...
The Best Stocks For 2020 - How to Spot Multibagger Ideas. FREE Sign up!
Free Report: The Secret to Increasing Your Trading Profits Daily!
Find Out Our Top 7 Bluechips for 2020 Virtually FREE. Click Here Now!

S&P BSE SENSEX


Mar 30, 2020 (Close)

OTHER USEFUL LINKS

MARKET STATS


ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS
PREMIUM PRODUCTS
QUICK LINKS
APPS
  • Get Equitymaster Android App on Google Play
  • Get Equitymaster iOS App on App Store
FOLLOW

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.